Disease/Infection News

RSS

Haiti faces 'largest' cholera epidemic in modern history, PAHO says

"Almost two years after the devastating 7.0 earthquake destroyed much of Port-au-Prince, full recovery appears to be years away," the Miami Herald reports, noting that "thousands of people continue to live in makeshift shelters and tents and rubble from dilapidated buildings still line some streets."

10 Jan 2012

CMS increases NLA for T-SPOT.TB test's CPT code 86481

Oxford Immunotec, Inc. announces that, following a reconsideration request made by the company, the Centers for Medicare and Medicaid Services has increased the national limitation amount (NLA) for the Current Procedural Terminology (CPT) code 86481 which is used for the T-SPOT.TB test.

10 Jan 2012

Congressional delegation visits Africa to assess impact of U.S.-sponsored projects

A Congressional delegation consisting of six senators and one representative arrived in Africa on Thursday for an eight-day trip that "includes oversight of Department of Defense, Department of State, and USAID activities in Africa," the Daily Republic reports.

10 Jan 2012

Modified probiotics could one day decrease risk of Listeria infection

Modified probiotics, the beneficial bacteria touted for their role in digestive health, could one day decrease the risk of Listeria infection in people with susceptible immune systems, according to Purdue University research.

10 Jan 2012

CNBG, Aeras reach final agreement to develop new TB vaccines

The global fight against the tuberculosis epidemic receives a boost today as Aeras and the China National Biotec Group (CNBG) announce that they have reached final agreement to jointly develop new tuberculosis (TB) vaccines.

10 Jan 2012

Positive interim data from Idenix IDX184 12-week phase IIb trial on HCV

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced interim data from a 12-week phase IIb clinical trial of IDX184, the Company's lead product candidate for the treatment of hepatitis C virus (HCV) infection.

9 Jan 2012

Idenix Pharmaceuticals makes progress with its HCV development pipeline

Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the advancement of its hepatitis C virus development pipeline.

9 Jan 2012

Sangamo BioSciences starts Phase 2 clinical studies to develop functional cure for HIV/AIDS

Sangamo BioSciences, Inc. announced today the initiation of two new Phase 2 clinical studies (SB-728-1101 and SB-728-902, Cohort 5) in its program to develop a "functional cure" for HIV/AIDS.

9 Jan 2012

Presidio completes PPI-668 Phase 1a study on hepatitis C

Presidio Pharmaceuticals, Inc. announced today the successful completion of a Phase 1a dose-ranging assessment of PPI-668, a potent, pan-genotypic second-generation hepatitis C virus (HCV) NS5A inhibitor, in healthy volunteers and subsequent advancement to a Phase 1b assessment of the dose-related efficacy in hepatitis C patients.

9 Jan 2012

Colby's JVRS-100 enhances immunogenicity, cross-protective efficacy of H5N1 influenza vaccine

Colby Pharmaceutical Company (CPC) today announced publication of new results showing that a single dose of JVRS-100 adjuvanted H5N1 influenza vaccine enhanced-immune responses, -dose sparing, and -cross-clade influenza virus protection.

9 Jan 2012

MPIIB, QIAGEN partner to develop latent TB diagnostic test

QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime.

From QIAGEN Manchester Limited 9 Jan 2012

Anthrax defenses need to be strengthened say experts

It has been a decade since the anthrax attacks brought home the reality of bioterrorism and the nation has a stockpile of some basic tools to fight back against a few of the threats that worry defense experts the most.

8 Jan 2012

Kenyan government adopts new HIV testing guidelines following WHO recall

"The Kenyan government has changed its HIV testing algorithm following the withdrawal of a widely used brand of HIV test [based] on warnings from" the WHO, PlusNews reports.

7 Jan 2012

Pennsylvania Department of Health to provide free influenza and Tdap vaccines

The Department of Health will offer free influenza and Tetanus, Diphtheria and Pertussis (Tdap) vaccines at the 2012 Pennsylvania Farm Show, Jan. 9-13, from 9 a.m. to 4 p.m. each day.

7 Jan 2012

Stimflora launches new dietary health product

An exciting new dietary health product has been launched which promotes healthy digestion while strengthening the immune system.

7 Jan 2012

Governments must rethink policies surrounding biosecurity, not resort to censorship

Author Laurie Garrett, senior fellow for global health at the Council on Foreign Relations, writes in this Foreign Policy opinion piece that the announcement researchers from the Netherlands and the U.S. have developed a supercontagious variety of bird flu "has highlighted a dilemma: How do you balance the universal mandate for scientific openness against the fear that terrorists or rogue states might follow the researchers' work -- using it as catastrophic cookbooks for global influenza contagion?"

7 Jan 2012

WHO confirms bird flu cases in Egypt, China

The WHO on Thursday "announced the deaths of two men from H5N1 avian influenza, one from Egypt and another from China whose death was reported earlier in the media," CIDRAP News reports. Both men are suspected to have contracted the virus from avian sources, although an investigation into the man from China's exposure to the virus is ongoing, according to news service.

7 Jan 2012

Street News Service/IPS examine challenges of fighting HIV/AIDS in a Senegalese prison

Street News Service/Inter Press Service examines how Senegal is addressing HIV/AIDS among prisoners in a Dakar maximum-security facility. "Prisons are high-risk environments for the transmission of the disease, due to the prevalence of hard drugs, violence and sexual relations," the news service writes and discusses how addressing such issues can present challenges in the majority-Muslim country.

7 Jan 2012

Researchers crack structure and function of malarial protein

A biology lab at Washington University has just cracked the structure and function of a protein that plays a key role in the life of a parasite that killed 655,000 people in 2010.

7 Jan 2012

Research roundup: New ethics guidelines for doctors urge cost consideration; HIV testing in teens

Today's research comes from the Annals of Internal Medicine, the Journal of the American Medical Association, the Archives of Pediatrics and Adolescent Medicine, George Washington University and the Robert Wood Johnson Foundation.

7 Jan 2012